PREDICTORS OF CASTRATION RESISTANT PROSTATE CANCER IN MEN UNDERGOING SALVAGE ANDROGEN DEPRIVATION THERAPY - RESULTS FROM THE SEARCH DATABASE

被引:0
|
作者
Banez, Lionel L.
Moreira, Daniel M.
Krupski, Tracey L.
Aronson, William J.
Presti, Joseph C., Jr.
Terris, Martha K.
Amling, Christopher L.
Kane, Christopher J.
Freedland, Stephen J.
机构
来源
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词
D O I
10.1016/S0022-5347(09)60832-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
818
引用
收藏
页码:292 / 292
页数:1
相关论文
共 50 条
  • [1] SERUM LIPID PROFILE AT TIME OF ANDROGEN DEPRIVATION THERAPY AND RISK OF CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE
    Dambal, Shweta
    Howard, Lauren
    Allott, Emma
    Aronson, William
    Kane, Christopher
    Amling, Christopher
    Cooperberg, Matthew
    Terris, Martha
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E262 - E263
  • [2] Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database
    Dambal, Shweta
    Howard, Lauren E.
    Allott, Emma H.
    Aronson, William J.
    Kane, Christopher J.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Terris, Martha K.
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2020, 203 (01): : 120 - 126
  • [3] Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database COMMENT
    Hamilton, Robert J.
    JOURNAL OF UROLOGY, 2020, 203 (01): : 126 - 127
  • [5] PREDICTORS OF SKELETAL RELATED EVENTS AND OVERALL MORTALITY IN MEN WITH METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE
    Tablazon, Ingrid Lorese
    Howard, Lauren
    De Hoedt, Amanda
    Aronson, William
    Kane, Christopher
    Amling, Christopher
    Cooperberg, Matthew
    Terris, Martha
    Freedland, Stephen
    Williams, Stephen
    JOURNAL OF UROLOGY, 2019, 201 (04): : E499 - E499
  • [6] Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database
    Keto, Christopher J.
    Aronson, William J.
    Terris, Martha K.
    Presti, Joseph C.
    Kane, Christopher J.
    Amling, Christopher L.
    Freedland, Stephen J.
    BJU INTERNATIONAL, 2012, 110 (04) : 492 - 498
  • [7] Androgen deprivation therapy and risk of diabetes mellitus in men undergoing androgen deprivation therapy for prostate cancer
    Kincade, MC
    Derweesh, IH
    Malcolm, J
    Lamar, KD
    Patterson, AL
    Kitabchi, AE
    Wake, R
    JOURNAL OF UROLOGY, 2006, 175 (04): : 41 - 41
  • [8] Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
    Marshall, Catherine H.
    Tunacao, Jessa
    Danda, Varun
    Tsai, Hua-Ling
    Barber, John
    Gawande, Rakhee
    Weiss, Clifford R.
    Denmeade, Samuel R.
    Joshu, Corinne
    BJU INTERNATIONAL, 2021, 128 (03) : 366 - 373
  • [9] Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer
    Hamilton, K.
    Chambers, S. K.
    Legg, M.
    Oliffe, J. L.
    Cormie, P.
    SUPPORTIVE CARE IN CANCER, 2015, 23 (01) : 133 - 142
  • [10] Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy
    M Braga-Basaria
    D C Muller
    M A Carducci
    A S Dobs
    S Basaria
    International Journal of Impotence Research, 2006, 18 : 494 - 498